Nomi Werbeloff

2.9k total citations
65 papers, 2.1k citations indexed

About

Nomi Werbeloff is a scholar working on Clinical Psychology, Psychiatry and Mental health and Social Psychology. According to data from OpenAlex, Nomi Werbeloff has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Clinical Psychology, 32 papers in Psychiatry and Mental health and 11 papers in Social Psychology. Recurrent topics in Nomi Werbeloff's work include Schizophrenia research and treatment (24 papers), Suicide and Self-Harm Studies (11 papers) and Mental Health Treatment and Access (10 papers). Nomi Werbeloff is often cited by papers focused on Schizophrenia research and treatment (24 papers), Suicide and Self-Harm Studies (11 papers) and Mental Health Treatment and Access (10 papers). Nomi Werbeloff collaborates with scholars based in Israel, United Kingdom and United States. Nomi Werbeloff's co-authors include Mark Weiser, Michael Davidson, Jim van Os, M. Weiser, Rinat Yoffe, Tineke Lataster, Marjan Drukker, Nil Kaymaz, Hans‐Ulrich Wïttchen and Roselind Lieb and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Nomi Werbeloff

62 papers receiving 2.1k citations

Peers

Countries citing papers authored by Nomi Werbeloff

Since Specialization

Citations

This map shows the geographic impact of Nomi Werbeloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nomi Werbeloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nomi Werbeloff more than expected).

Fields of papers citing papers by Nomi Werbeloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nomi Werbeloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nomi Werbeloff. The network helps show where Nomi Werbeloff may publish in the future.

Co-authorship network of co-authors of Nomi Werbeloff

This figure shows the co-authorship network connecting the top 25 collaborators of Nomi Werbeloff. A scholar is included among the top collaborators of Nomi Werbeloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nomi Werbeloff. Nomi Werbeloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antipsychotic polypharmacy and adverse drug reactions among adults in a London mental health service, 2008–2018 2022 ·Psychological Medicine ·Justin Yang, Johan H. Thygesen, Nomi Werbeloff, Joseph Hayes, David Osborn	0
2	Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data 2021 ·International Journal of Geriatric Psychiatry ·Andrew Sommerlad, Nomi Werbeloff, Gayan Perera, (unknown), Harry Costello, Christoph Mueller, Andrey Kormilitzin, Matthew Broadbent, Alejo Nevado‐Holgado, Simon Lovestone, Robert Stewart, Gill Livingston	9
3	Mental health-related conversations on social media and crisis episodes: a time-series regression analysis 2020 ·Scientific Reports ·Anna Kolliakou, Ioannis Bakolis, David Chandran, Leon Derczynski, Nomi Werbeloff, David Osborn, Kalina Bontcheva, Robert Stewart	18
4	Characteristics and risk of repeat suicidal ideation and self-harm in patients who present to emergency departments with suicidal ideation or self-harm: A prospective cohort study 2020 ·Journal of Affective Disorders ·Rachel L. Cripps, Joseph Hayes, Alexandra Pitman, David Osborn, Nomi Werbeloff	6
5	Patterns of use of the Mental Health Act 1983, from 2007–2008 to 2016–2017, in two major London secondary mental healthcare providers 2019 ·BJPsych Open ·Siân Oram, (unknown), Megan Pritchard, Mizanur Khondoker, Daniela Fonseca de Freitas, (unknown), Johnny Downs, Brynmor Lloyd‐Evans, Sarah Markham, Nomi Werbeloff, Chin‐Kuo Chang, Sonia Johnson, Matthew Hotopf, Richard D. Hayes	2
6	The Camden & Islington Research Database: Using electronic mental health records for research 2018 ·PLoS ONE ·Nomi Werbeloff, David Osborn, Rashmi Patel, Matthew Taylor, Robert Stewart, Matthew Broadbent, Joseph Hayes	22
7	Diagnosed depression and sociodemographic factors as predictors of mortality in patients with dementia 2018 ·The British Journal of Psychiatry ·Gemma Lewis, Nomi Werbeloff, Joseph Hayes, Robert Howard, David Osborn	18
8	Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials 2016 ·The British Journal of Psychiatry ·Jonathan Rabinowitz, Nomi Werbeloff, Francine S. Mandel, François Ménard, Lauren B. Marangell, Shitij Kapur	42
9	Individual and area-level risk factors for suicidal ideation and attempt in people with severe depression 2016 ·Journal of Affective Disorders ·Nomi Werbeloff, (unknown), Joseph Hayes, Alexandra Pitman, David Osborn	18
10	The association between premorbid cognitive ability and social functioning and suicide among young men: A historical-prospective cohort study 2016 ·European Neuropsychopharmacology ·Mark Weiser, Daphna Fenchel, Nomi Werbeloff, Shira Goldberg, Eyal Fruchter, Abraham Reichenberg, (unknown), Matthew Large, Michael Davidson, Gad Lubin	6
11	Mental health medication and service utilisation before, during and after war: a nested case–control study of exposed and non-exposed general population, ‘at risk’, and severely mentally ill cohorts 2015 ·Epidemiology and Psychiatric Sciences ·(unknown), Arad Kodesh, Nomi Werbeloff	1
12	A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ 2015 ·Schizophrenia Research ·Mark Weiser, (unknown), Nomi Werbeloff, Shira Goldberg, Daphna Fenchel, Abraham Reichenberg, Rinat Yoffe, (unknown), Eyal Fruchter, Michael Davidson	11
13	Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences 2013 ·Schizophrenia Research ·Jonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, Francine S. Mandel, Virginia L. Stauffer, François Ménard, Bruce J. Kinon, Shitij Kapur	65
14	Combining efficacy and completion rates with no data imputation: A composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials 2013 ·European Neuropsychopharmacology ·Jonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, Francine S. Mandel, Judith Jaeger, Virginia L. Stauffer, François Ménard, Bruce J. Kinon, Shitij Kapur	1
15	Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results 2012 ·Psychological Medicine ·Nil Kaymaz, Marjan Drukker, Roselind Lieb, Hans‐Ulrich Wïttchen, Nomi Werbeloff, M. Weiser, Tineke Lataster, Jim van Os	336
16	THE CASE OF THE MISSING EVIDENCE: DO PSYCHOTIC EXPERIENCES PREDICT CLINICAL OUTCOMES IN UNSELECTED POPULATION-BASED SAMPLES? A SYSTEMATIC REVIEW AND META-ANALYSIS, ENRICHED WITH NEW RESULTS 2011 ·Max Planck Institute for Plasma Physics ·Jim van Os, Nil Kaymaz, Tineke Lataster, Roselind Lieb, Hans‐Ulrich Wïttchen, Mark Weiser, Nomi Werbeloff, Marjan Drukker	1
17	Do persons with severe mental illness who consume the psychiatric rehabilitation basket of services in Israel have better outcomes than those who do not? 2010 ·PubMed ·David Roe, Nomi Werbeloff, Marc Gelkopf	18
18	Decrease in Suicide Rates After a Change of Policy Reducing Access to Firearms in Adolescents: A Naturalistic Epidemiological Study 2010 ·Suicide and Life-Threatening Behavior ·Gad Lubin, Nomi Werbeloff, Demian Halperin, (unknown), Mark Weiser, Haim Y. Knobler	120
19	Cognitive test scores in male adolescent cigarette smokers compared to non‐smokers: a population‐based study 2009 ·Addiction ·Mark Weiser, Salman Zarka, Nomi Werbeloff, Efrat Kravitz, Gad Lubin	42
20	Increased number of offspring in first degree relatives of psychotic individuals: a partial explanation for the persistence of psychotic illnesses 2009 ·Acta Psychiatrica Scandinavica ·Mark Weiser, Avi Reichenberg, Nomi Werbeloff, Daniel Halpérin, Efrat Kravitz, Rinat Yoffe, Michael Davidson	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact